Show simple item record

dc.contributor.authorPrice, David
dc.contributor.authorMenzies-Gow, Andrew N
dc.contributor.authorBachert, Claus
dc.contributor.authorCanonica, Giorgio Walter
dc.contributor.authorKocks, Janwillem W H
dc.contributor.authorKhan, Asif H.
dc.contributor.authorYe, Feng
dc.contributor.authorRowe, Paul
dc.contributor.authorLu, Yufang
dc.contributor.authorKamat, Siddhesh
dc.contributor.authorCarter, Victoria
dc.contributor.authorVoorham, Jaco
dc.date.accessioned2021-09-29T08:20:01Z
dc.date.available2021-09-29T08:20:01Z
dc.date.issued2021-09-29
dc.identifier.citationPrice , D , Menzies-Gow , A N , Bachert , C , Canonica , G W , Kocks , J W H , Khan , A H , Ye , F , Rowe , P , Lu , Y , Kamat , S , Carter , V & Voorham , J 2021 , ' Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma ' , Journal of Asthma and Allergy , vol. 2021 , no. 14 , pp. 1173—1183 . https://doi.org/10.2147/JAA.S321212en
dc.identifier.issn1178-6965
dc.identifier.otherPURE: 200289350
dc.identifier.otherPURE UUID: 88ea0948-c91d-4a25-b20c-61b77d42a4f7
dc.identifier.otherSCOPUS: 85116490641
dc.identifier.otherScopus: 85116490641
dc.identifier.urihttps://hdl.handle.net/2164/17206
dc.descriptionFunding This study was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Acknowledgments At the time of development of this manuscript, Fen Ye was an employee of Sanofi and Yufang Lu was an employee of Regeneron Pharmaceuticals.Medical writing support was provided by Abby Armitt, MSc, and Gauri Saal, MA Economics, of Prime, Knutsford, UK, and funded by Sanofi and Regeneron Pharmaceuticals, Inc.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofJournal of Asthma and Allergyen
dc.rights© 2021 Price et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)en
dc.subjecttype 2 inflammationen
dc.subjectasthmaen
dc.subjectexacerbationsen
dc.subjectcontrolen
dc.subjectburdenen
dc.subjectcomorbiditiesen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleAssociation Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthmaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.2147/JAA.S321212


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record